|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Caladrius Biosciences (NASDAQ: CLBS) through any online brokerage.
The latest price target for Caladrius Biosciences (NASDAQ: CLBS) was reported by Brookline Capital on 2021-03-03. The analyst firm set a price target for 10.00 expecting CLBS to rise to within 12 months (a possible 458.66% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Caladrius Biosciences (NASDAQ: CLBS) is $1.79 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Caladrius Biosciences.
There is no upcoming split for Caladrius Biosciences.